Skip to NavigationSkip to content

News

New research could revolutionise this process by allowing tracking of the disease by a simple blood test. Researchers struck upon a test that...
AbbVie posted results on upadacitinib, the latest drug in its pipeline for rheumatoid arthritis (RA) and the results have given the company a huge...
Pfizer’s tafamidis has already been given approval in 40 countries across the globe but it has not currently broken into the US market. This could...
A recent study, conducted by the University of Cambridge, has found that DNA plays a part in determining an individual’s ability to empathise with...
Novartis is to join forces with tech giant IBM and its Watson Health platform to tackle advanced breast cancer with an outcome-based initiative.
In a study examining patients suffering from multiple myeloma, CAR-T therapy achieved a 100% response rate across all participants, with every one...
Takeda has officially launched the construction of a new €40 million production facility in Dublin, Ireland, with a ground-breaking ceremony.
New research data from the Mayo Clinic has suggested that as much as one in six patients suffering from atrial fibrillation have been prescribed...
Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust regulations back...
The University of Oxford has joined forces with the Netherlands Cancer Institute (NKI) in an international collaboration known as Scenic Biotech,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches